Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
sector : Health technology source : Www.curevac.com save search
CureVac veröffentlicht Finanzergebnisse für das erste Quartal 2023 und informiert über seine Geschäftsentwicklung
Published: 2023-05-30 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.3%
H: 0.36%
C: 0.36%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.18%
H: 0.0%
C: -1.28%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.64%
C: -3.06%
CureVac gibt Entwicklungen im Patentrechtsstreit mit Pfizer/BioNTech bekannt
Published: 2023-05-19 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.67%
H: 1.53%
C: 0.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.14%
H: 1.45%
C: 1.28%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.91%
H: 4.53%
C: 2.49%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: 0.37%
H: 1.96%
C: 1.09%
CureVac gibt Impfung des ersten Teilnehmers in kombinierter Phase 1/2-Studie für multivalente, modifizierte Grippe-Impfstoffkandidaten bekannt, entwickelt in Zusammenarbeit mit GSK
Published: 2023-05-08 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 4.81%
H: 0.0%
C: -6.12%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.24%
H: 0.3%
C: -0.81%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.0%
H: 4.98%
C: 2.55%
CureVac veröffentlicht Finanzergebnisse für das vierte Quartal sowie das Gesamtjahr 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-25 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.22%
H: 4.05%
C: 4.05%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.64%
H: 0.19%
C: -0.91%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -1.3%
H: 2.24%
C: -4.35%
CureVac veröffentlicht am 25. April 2023 Finanzergebnisse des vierten Quartals sowie des Gesamtjahres 2022 und informiert über seine Geschäftsentwicklung
Published: 2023-04-18 (Crawled : 11:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -6.76%
H: 3.18%
C: 1.34%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.64%
H: 0.23%
C: -1.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.13%
H: 1.13%
C: 0.0%
[English only] CureVac Announces Voting Results of Extraordinary General Meeting
Published: 2023-03-28 (Crawled : 21:00) - curevac.com
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.39%
H: 4.26%
C: 3.88%
meeting results
CureVac gibt Abschluss des öffentlichen Zeichnungsangebots mit Erlös von 250 Millionen US-Dollar bekannt
Published: 2023-02-10 (Crawled : 22:00) - curevac.com
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
| Email alert
Add to watchlist
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
| Email alert
Add to watchlist
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
| Email alert
Add to watchlist
CureVac gibt Preisgestaltung des erhöhten öffentlichen Angebots von Stammaktien bekannt
Published: 2023-02-08 (Crawled : 02:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.99%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.08%
H: 0.08%
C: -0.66%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.11%
H: 0.64%
C: -2.56%
CureVac kündigt geplantes Angebot von Stammaktien an
Published: 2023-02-06 (Crawled : 22:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 3.77%
H: 0.0%
C: -1.96%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 1.84%
H: 0.5%
C: 0.5%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -6.62%
H: 1.11%
C: -5.06%
CureVac begrüßt Dr. Myriam Mendila als neuen Chief Development Officer
Published: 2023-02-01 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.91%
H: 0.0%
C: -1.42%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.0%
H: 1.5%
C: 0.65%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 0.74%
H: 8.96%
C: 8.96%
als
CureVac von LexisNexis® als einer der weltweit dynamischsten Innovatoren ausgezeichnet
Published: 2023-01-31 (Crawled : 13:20) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.04%
H: 0.0%
C: -3.67%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.85%
H: 0.31%
C: -0.45%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -1.73%
H: 3.25%
C: -5.62%
lexisnexis als
CureVac veröffentlicht positive Daten bei älteren Erwachsenen aus COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen
Published: 2023-01-30 (Crawled : 12:20) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -2.59%
H: 3.12%
C: 1.79%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.74%
H: 0.2%
C: -1.24%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 5.36%
H: 4.0%
C: -3.5%
covid-19 positive
CureVac ernennt Alexander Zehnder zum Vorstandsvorsitzenden ab 1. April 2023
Published: 2023-01-09 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 1.9%
H: 0.0%
C: -1.81%
SNYNF | News | $94.25 -2.18% 480
|
Health Technology
|
| O: 1.38%
H: 0.28%
C: 0.28%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.11%
H: 0.69%
C: -1.23%
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 1.82%
H: 0.0%
C: 0.0%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 22.46%
H: 10.13%
C: 2.42%
CureVac gibt positive Daten aus gemeinsamen COVID-19- und Grippe-mRNA-Impfstoffentwicklungsprogrammen bekannt
Published: 2023-01-06 (Crawled : 12:20) - curevac.com
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.44%
H: 1.85%
C: 1.72%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 12.7%
H: 15.44%
C: 14.88%
covid-19 positive
CureVac-Mitglieder der Geschäftsleitung verkaufen Aktien zur Deckung steuerlicher Verpflichtungen aus Long Term Incentive Programm
Published: 2022-12-14 (Crawled : 22:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -1.57%
H: 2.23%
C: 2.23%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 0.36%
H: 0.28%
C: -1.17%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -1.39%
H: 1.41%
C: -4.24%
CureVac veröffentlicht Finanzergebnisse für das dritte Quartal sowie die ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-16 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 0.0%
H: 2.85%
C: 2.85%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.69%
H: 0.27%
C: -0.75%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -2.73%
H: 5.99%
C: 4.08%
CureVac veröffentlicht vorläufige Daten der Phase 1-Erweiterungsstudie mit Onkologie-Kandidaten CV8102
Published: 2022-11-11 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: 2.8%
H: 1.16%
C: -2.72%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -4.96%
H: 0.28%
C: -0.72%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 2.72%
H: 7.28%
C: -2.78%
cv8102 phase 1
CureVac veröffentlicht am 16. November 2022 Finanzergebnisse des dritten Quartals sowie der ersten neun Monate 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-11-10 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -0.06%
H: 0.0%
C: 0.0%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: 2.59%
H: 0.72%
C: 0.63%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: 3.14%
H: 2.63%
C: 1.94%
CureVac beginnt mit klinischer Phase 1-Studie für modifizierten COVID-19-Impfstoffkandidaten gegen Omikron-Variante
Published: 2022-08-18 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -3.07%
H: 9.03%
C: 4.86%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.03%
C: -0.98%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -0.61%
H: 1.64%
C: -4.58%
covid-19 phase 1
CureVac veröffentlicht Finanzergebnisse für das zweite Quartal und erste Halbjahr 2022 und informiert über seine Geschäftsentwicklung
Published: 2022-08-18 (Crawled : 12:00) - curevac.com
GLAXF | News | $19.54 -14.18% 2.6K
|
Health Technology
|
| O: -3.07%
H: 9.03%
C: 4.86%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.03%
C: -0.98%
CVAC | $2.51 -3.46% -3.59% 1.1M
|
Health Technology
|
| O: -0.61%
H: 1.64%
C: -4.58%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -0.21%
H: 0.3%
C: -2.71%
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.